Identification of Cancer-Specific Glycoproteins in Triple-Negative Breast Cancer

被引：0
|
作者：
Tseng, L. H.
Argani, P.
Li, Y.
Tian, Y.
Lopez, M. F.
Sarracino, D.
Rezai, T.
Athanas, M.
Krastins, B.
Chan, D. W.
Zhang, H.
机构：
[1] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
[2] Thermo Fisher Sci, Cambridge, MA USA
[3] VAST Sci, Cambridge, MA USA
来源：
MODERN PATHOLOGY | 2009年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
313
引用
收藏
页码：72A / 72A
页数：1
相关论文
共 50 条
  • [1] Identification of Cancer-Specific Glycoproteins in Triple-Negative Breast Cancer
    Tseng, L. H.
    Argani, P.
    Li, Y.
    Tian, Y.
    Lopez, M. F.
    Sarracino, D.
    Rezai, T.
    Athanas, M.
    Krastins, B.
    Chan, D. W.
    Zhang, H.
    [J]. LABORATORY INVESTIGATION, 2009, 89 : 72A - 72A
  • [2] Cancer-Specific Outcomes in the Elderly with Triple-Negative Breast Cancer: A Systematic Review
    Yoon, Jenny
    Knapp, Gregory
    Quan, May Lynn
    Bouchard-Fortier, Antoine
    [J]. CURRENT ONCOLOGY, 2021, 28 (04) : 2337 - 2345
  • [3] Have all triple-negative breast cancer patients worse breast cancer-specific survival?
    Altundag, Kadri
    [J]. BREAST, 2017, 36 : 102 - 102
  • [4] Omitting radiotherapy in triple-negative breast cancer leads to worse cancer-specific survival
    Kindts, I.
    Buelens, P.
    Laenen, A.
    Van Limbergen, E.
    Janssen, H.
    Wildiers, H.
    Weltens, C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S339 - S340
  • [5] Impact of Adjuvant Radiation Therapy on Breast Cancer-Specific Survival in Patients With Triple-Negative Breast Cancer
    Margenthaler, Julie A.
    Cyr, Amy E.
    Zoberi, Imran
    Gao, Feng
    Taylor, Marie
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : 82 - 82
  • [6] Targeting a Cancer-Specific Epitope of the Epidermal Growth Factor Receptor in Triple-Negative Breast Cancer
    Simon, Nathan
    Antignani, Antonella
    Sarnovsky, Robert
    Hewitt, Stephen M.
    FitzGerald, David
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (08)
  • [7] In Silico Analysis of Publicly Available Transcriptomic Data for the Identification of Triple-Negative Breast Cancer-Specific Biomarkers
    Kaddoura, Rachid
    Alqutami, Fatma
    Asbaita, Mohamed
    Hachim, Mahmood
    [J]. LIFE-BASEL, 2023, 13 (02):
  • [8] Estimating risk of breast cancer-specific mortality (BCSM) and non-BCSM in patients with triple-negative breast cancer
    Leone, Jose P.
    Graham, Noah
    Leone, Julieta
    Tolaney, Sara M.
    Leone, Bernardo A.
    Freedman, Rachel A.
    Hassett, Michael J.
    Vallejo, Carlos T.
    Winer, Eric P.
    Lin, Nancy U.
    Tayob, Nabihah
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [9] Development and validation of nomograms for predicting overall and breast cancer-specific survival among patients with triple-negative breast cancer
    Guo, Lin-Wei
    Jiang, Lin-Miao
    Gong, Yue
    Zhang, Hong-Hua
    Li, Xiao-Guang
    He, Min
    Sun, Wei-Li
    Ling, Hong
    Hu, Xin
    [J]. CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 5881 - 5894
  • [10] Identification of FOXM1 as a specific marker for triple-negative breast cancer
    Tan, Yanli
    Wang, Qixue
    Xie, Yingbin
    Qiao, Xiaoxia
    Zhang, Shun
    Wang, Yanan
    Yang, Yongbin
    Zhang, Bo
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2019, 54 (01) : 87 - 97
12345